{"transactions":[{"id":1776022,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-09-20T16:21:21.000Z","date":"2023-09-18","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.2365,"value":4730.0,"ownership":{"direct":true},"balance_after":1533949,"source":{"system":"sec-edgar","filing":"0001493152-23-033155","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223033155/ownership.xml","form_type":"4"}},{"id":1858389,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-06-12T20:37:34.000Z","date":"2023-06-09","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":0.4325,"value":1297.5,"ownership":{"direct":true},"balance_after":1513949,"source":{"system":"sec-edgar","filing":"0001493152-23-020928","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223020928/ownership.xml","form_type":"4"}},{"id":1858388,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-06-12T20:37:34.000Z","date":"2023-06-02","kind":"grant","planned":false,"acquired":true,"shares":760000,"price":0.5,"value":380000.0,"ownership":{"direct":true},"balance_after":1510949,"source":{"system":"sec-edgar","filing":"0001493152-23-020928","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223020928/ownership.xml","form_type":"4"}},{"id":1880786,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-05-23T21:24:30.000Z","date":"2023-05-23","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":0.498,"value":249.0,"ownership":{"direct":true},"balance_after":751449,"source":{"system":"sec-edgar","filing":"0001493152-23-018753","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223018753/ownership.xml","form_type":"4"}},{"id":1880785,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-05-23T21:24:30.000Z","date":"2023-05-19","kind":"purchase","planned":false,"acquired":true,"shares":1500,"price":0.52,"value":780.0,"ownership":{"direct":true},"balance_after":750949,"source":{"system":"sec-edgar","filing":"0001493152-23-018753","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223018753/ownership.xml","form_type":"4"}},{"id":1880784,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-05-23T21:24:30.000Z","date":"2023-05-19","kind":"purchase","planned":false,"acquired":true,"shares":4500,"price":0.51,"value":2295.0,"ownership":{"direct":true},"balance_after":746449,"source":{"system":"sec-edgar","filing":"0001493152-23-018753","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223018753/ownership.xml","form_type":"4"}},{"id":1899206,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-05-09T23:11:21.000Z","date":"2023-05-09","kind":"purchase","planned":false,"acquired":true,"shares":2300,"price":0.377,"value":867.1,"ownership":{"direct":true},"balance_after":741949,"source":{"system":"sec-edgar","filing":"0001493152-23-016009","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223016009/ownership.xml","form_type":"4"}},{"id":1899205,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-05-09T23:11:21.000Z","date":"2023-05-08","kind":"purchase","planned":false,"acquired":true,"shares":1500,"price":0.43,"value":645.0,"ownership":{"direct":true},"balance_after":739649,"source":{"system":"sec-edgar","filing":"0001493152-23-016009","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223016009/ownership.xml","form_type":"4"}},{"id":1899204,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-05-09T23:11:21.000Z","date":"2023-05-05","kind":"purchase","planned":false,"acquired":true,"shares":11500,"price":0.49,"value":5635.0,"ownership":{"direct":true},"balance_after":738149,"source":{"system":"sec-edgar","filing":"0001493152-23-016009","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223016009/ownership.xml","form_type":"4"}},{"id":1913209,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-04-26T23:38:40.000Z","date":"2023-04-26","kind":"purchase","planned":false,"acquired":true,"shares":5500,"price":0.3976,"value":2186.8,"ownership":{"direct":true},"balance_after":726649,"source":{"system":"sec-edgar","filing":"0001493152-23-013730","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223013730/ownership.xml","form_type":"4"}},{"id":1913208,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-04-26T23:38:40.000Z","date":"2023-04-25","kind":"purchase","planned":false,"acquired":true,"shares":3500,"price":0.3803,"value":1331.05,"ownership":{"direct":true},"balance_after":721149,"source":{"system":"sec-edgar","filing":"0001493152-23-013730","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223013730/ownership.xml","form_type":"4"}},{"id":1913207,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-04-26T23:38:40.000Z","date":"2023-04-25","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":0.32,"value":320.0,"ownership":{"direct":true},"balance_after":717649,"source":{"system":"sec-edgar","filing":"0001493152-23-013730","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223013730/ownership.xml","form_type":"4"}},{"id":1923485,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-04-07T00:18:09.000Z","date":"2023-04-05","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":0.33,"value":825.0,"ownership":{"direct":true},"balance_after":716649,"source":{"system":"sec-edgar","filing":"0001493152-23-011314","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223011314/ownership.xml","form_type":"4"}},{"id":1923484,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-04-07T00:18:09.000Z","date":"2023-04-04","kind":"purchase","planned":false,"acquired":true,"shares":3200,"price":0.35,"value":1120.0,"ownership":{"direct":true},"balance_after":714149,"source":{"system":"sec-edgar","filing":"0001493152-23-011314","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223011314/ownership.xml","form_type":"4"}},{"id":1923483,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-04-07T00:18:09.000Z","date":"2023-04-03","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":0.36,"value":360.0,"ownership":{"direct":true},"balance_after":710949,"source":{"system":"sec-edgar","filing":"0001493152-23-011314","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223011314/ownership.xml","form_type":"4"}},{"id":1983057,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-03-01T21:21:11.000Z","date":"2023-02-27","kind":"purchase","acquired":true,"shares":1000,"price":0.19,"value":190.0,"ownership":{"direct":true},"balance_after":709949,"source":{"system":"sec-edgar","filing":"0001493152-23-006398","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223006398/ownership.xml","form_type":"4"}},{"id":1983056,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-03-01T21:21:11.000Z","date":"2023-02-27","kind":"purchase","acquired":true,"shares":2000,"price":0.1725,"value":345.0,"ownership":{"direct":true},"balance_after":708949,"source":{"system":"sec-edgar","filing":"0001493152-23-006398","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223006398/ownership.xml","form_type":"4"}},{"id":1983055,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-03-01T21:21:11.000Z","date":"2023-02-26","kind":"purchase","acquired":true,"shares":1000,"price":0.19,"value":190.0,"ownership":{"direct":true},"balance_after":706949,"source":{"system":"sec-edgar","filing":"0001493152-23-006398","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223006398/ownership.xml","form_type":"4"}},{"id":2041891,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-12-01","kind":"purchase","acquired":true,"shares":1000,"price":0.095,"value":95.0,"ownership":{"direct":true},"balance_after":705949,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2041890,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-11-29","kind":"purchase","acquired":true,"shares":2000,"price":0.125,"value":250.0,"ownership":{"direct":true},"balance_after":704949,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2041889,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-11-23","kind":"purchase","acquired":true,"shares":3000,"price":0.1,"value":300.0,"ownership":{"direct":true},"balance_after":702949,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2041888,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-09-13","kind":"purchase","acquired":true,"shares":1000,"price":0.1005,"value":100.5,"ownership":{"direct":true},"balance_after":699949,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2041887,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-08-19","kind":"purchase","acquired":true,"shares":6500,"price":0.1569,"value":1019.85,"ownership":{"direct":true},"balance_after":698949,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2041886,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-08-18","kind":"purchase","acquired":true,"shares":1000,"price":0.1699,"value":169.9,"ownership":{"direct":true},"balance_after":692449,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2041885,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-08-11","kind":"purchase","acquired":true,"shares":2000,"price":0.126,"value":252.0,"ownership":{"direct":true},"balance_after":691449,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2041884,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-08-09","kind":"purchase","acquired":true,"shares":1000,"price":0.1399,"value":139.9,"ownership":{"direct":true},"balance_after":689449,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2041883,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-07-26","kind":"purchase","acquired":true,"shares":1100,"price":0.12,"value":132.0,"ownership":{"direct":true},"balance_after":688449,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2041882,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-07-22","kind":"purchase","acquired":true,"shares":400,"price":0.294,"value":117.6,"ownership":{"direct":true},"balance_after":687349,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2041881,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-07-15","kind":"purchase","acquired":true,"shares":400,"price":0.416,"value":166.4,"ownership":{"direct":true},"balance_after":686949,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2041880,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-07-14","kind":"purchase","acquired":true,"shares":200,"price":0.4468,"value":89.36,"ownership":{"direct":true},"balance_after":686549,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2041879,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-06-29","kind":"purchase","acquired":true,"shares":2500,"price":0.2999,"value":749.75,"ownership":{"direct":true},"balance_after":683849,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2041878,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-06-21","kind":"purchase","acquired":true,"shares":3700,"price":0.39,"value":1443.0,"ownership":{"direct":true},"balance_after":681349,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2041877,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-06-17","kind":"purchase","acquired":true,"shares":9600,"price":0.282,"value":2707.2,"ownership":{"direct":true},"balance_after":677649,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2041876,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-06-16","kind":"purchase","acquired":true,"shares":500,"price":0.126,"value":63.0,"ownership":{"direct":true},"balance_after":668049,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2041875,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-06-14","kind":"purchase","acquired":true,"shares":500,"price":0.1821,"value":91.05,"ownership":{"direct":true},"balance_after":667549,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2041874,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-06-06","kind":"purchase","acquired":true,"shares":300,"price":0.4251,"value":127.53,"ownership":{"direct":true},"balance_after":667049,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2041873,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-05-23","kind":"purchase","acquired":true,"shares":100,"price":0.5,"value":50.0,"ownership":{"direct":true},"balance_after":666749,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2041872,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-05-17","kind":"purchase","acquired":true,"shares":100,"price":0.4999,"value":49.99,"ownership":{"direct":true},"balance_after":666649,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2041871,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-05-16","kind":"purchase","acquired":true,"shares":200,"price":0.4159,"value":83.18,"ownership":{"direct":true},"balance_after":666549,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2041870,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-02-16","kind":"purchase","acquired":true,"shares":100,"price":0.698,"value":69.8,"ownership":{"direct":true},"balance_after":666349,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2041869,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-02-11","kind":"purchase","acquired":true,"shares":200,"price":0.688,"value":137.6,"ownership":{"direct":true},"balance_after":666249,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2041868,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-01-25","kind":"purchase","acquired":true,"shares":700,"price":0.8499,"value":594.93,"ownership":{"direct":true},"balance_after":666049,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2041867,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-01-20","kind":"purchase","acquired":true,"shares":2300,"price":0.655,"value":1506.5,"ownership":{"direct":true},"balance_after":665349,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2041866,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-01-19","kind":"purchase","acquired":true,"shares":1000,"price":0.71,"value":710.0,"ownership":{"direct":true},"balance_after":663049,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2041865,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T11:10:12.000Z","date":"2022-01-18","kind":"purchase","acquired":true,"shares":1100,"price":0.713,"value":784.3,"ownership":{"direct":true},"balance_after":662049,"source":{"system":"sec-edgar","filing":"0001493152-23-002844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002844/ownership.xml","form_type":"5"}},{"id":2171488,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-08-29T20:01:40.000Z","date":"2022-08-26","kind":"purchase","acquired":true,"shares":1000,"price":0.15,"value":150.0,"ownership":{"direct":true},"balance_after":660949,"source":{"system":"sec-edgar","filing":"0001493152-22-024273","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222024273/ownership.xml","form_type":"4"}},{"id":2171487,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-08-29T20:01:40.000Z","date":"2022-08-26","kind":"purchase","acquired":true,"shares":2500,"price":0.1255,"value":313.75,"ownership":{"direct":true},"balance_after":659949,"source":{"system":"sec-edgar","filing":"0001493152-22-024273","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222024273/ownership.xml","form_type":"4"}},{"id":2171486,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-08-29T20:01:40.000Z","date":"2022-08-26","kind":"purchase","acquired":true,"shares":11500,"price":0.1378,"value":1584.7,"ownership":{"direct":true},"balance_after":657449,"source":{"system":"sec-edgar","filing":"0001493152-22-024273","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222024273/ownership.xml","form_type":"4"}},{"id":2185324,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":124575,"kind":"person","name":"Wert Lawrence","position":1,"cik":"0001626623","reported_name":"Wert Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-15T12:30:48.000Z","date":"2022-08-11","kind":"purchase","acquired":true,"shares":5000,"price":0.135,"value":675.0,"ownership":{"direct":true},"balance_after":1322868,"source":{"system":"sec-edgar","filing":"0001493152-22-022609","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222022609/ownership.xml","form_type":"4"}},{"id":2185323,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":124575,"kind":"person","name":"Wert Lawrence","position":1,"cik":"0001626623","reported_name":"Wert Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-15T12:30:48.000Z","date":"2022-08-11","kind":"purchase","acquired":true,"shares":5000,"price":0.128,"value":640.0,"ownership":{"direct":true},"balance_after":1317868,"source":{"system":"sec-edgar","filing":"0001493152-22-022609","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222022609/ownership.xml","form_type":"4"}},{"id":2185322,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":124575,"kind":"person","name":"Wert Lawrence","position":1,"cik":"0001626623","reported_name":"Wert Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-15T12:30:48.000Z","date":"2022-08-11","kind":"purchase","acquired":true,"shares":5000,"price":0.129,"value":645.0,"ownership":{"direct":true},"balance_after":1312868,"source":{"system":"sec-edgar","filing":"0001493152-22-022609","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222022609/ownership.xml","form_type":"4"}},{"id":2192937,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-08-05T15:17:03.000Z","date":"2022-08-04","kind":"purchase","acquired":true,"shares":1000,"price":0.093,"value":93.0,"ownership":{"direct":true},"balance_after":645949,"source":{"system":"sec-edgar","filing":"0001493152-22-021447","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222021447/ownership.xml","form_type":"4"}},{"id":2192936,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-08-05T15:17:03.000Z","date":"2022-08-04","kind":"purchase","acquired":true,"shares":500,"price":0.098,"value":49.0,"ownership":{"direct":true},"balance_after":644949,"source":{"system":"sec-edgar","filing":"0001493152-22-021447","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222021447/ownership.xml","form_type":"4"}},{"id":2192935,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-08-05T15:17:03.000Z","date":"2022-08-04","kind":"purchase","acquired":true,"shares":100,"price":0.11,"value":11.0,"ownership":{"direct":true},"balance_after":644449,"source":{"system":"sec-edgar","filing":"0001493152-22-021447","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222021447/ownership.xml","form_type":"4"}},{"id":2192934,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-08-05T15:17:03.000Z","date":"2022-08-04","kind":"purchase","acquired":true,"shares":5000,"price":0.1,"value":500.0,"ownership":{"direct":true},"balance_after":644349,"source":{"system":"sec-edgar","filing":"0001493152-22-021447","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222021447/ownership.xml","form_type":"4"}},{"id":2192933,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-08-05T15:17:03.000Z","date":"2022-08-04","kind":"purchase","acquired":true,"shares":2600,"price":0.1,"value":260.0,"ownership":{"direct":true},"balance_after":639349,"source":{"system":"sec-edgar","filing":"0001493152-22-021447","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222021447/ownership.xml","form_type":"4"}},{"id":2192932,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-08-05T15:17:03.000Z","date":"2022-08-04","kind":"purchase","acquired":true,"shares":2500,"price":0.093,"value":232.5,"ownership":{"direct":true},"balance_after":636749,"source":{"system":"sec-edgar","filing":"0001493152-22-021447","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222021447/ownership.xml","form_type":"4"}},{"id":2192931,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-08-05T15:17:03.000Z","date":"2022-08-04","kind":"purchase","acquired":true,"shares":1000,"price":0.1,"value":100.0,"ownership":{"direct":true},"balance_after":634249,"source":{"system":"sec-edgar","filing":"0001493152-22-021447","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222021447/ownership.xml","form_type":"4"}},{"id":2192930,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-08-05T15:17:03.000Z","date":"2022-08-04","kind":"purchase","acquired":true,"shares":5100,"price":0.1,"value":510.0,"ownership":{"direct":true},"balance_after":633249,"source":{"system":"sec-edgar","filing":"0001493152-22-021447","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222021447/ownership.xml","form_type":"4"}},{"id":2192929,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-08-05T15:17:03.000Z","date":"2022-08-03","kind":"purchase","acquired":true,"shares":1000,"price":0.0955,"value":95.5,"ownership":{"direct":true},"balance_after":628149,"source":{"system":"sec-edgar","filing":"0001493152-22-021447","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222021447/ownership.xml","form_type":"4"}},{"id":2208465,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-07-12T20:05:10.000Z","date":"2022-07-11","kind":"purchase","acquired":true,"shares":2100,"price":0.3979,"value":835.59,"ownership":{"direct":true},"balance_after":627149,"source":{"system":"sec-edgar","filing":"0001493152-22-019076","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222019076/ownership.xml","form_type":"4"}},{"id":2208464,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-07-12T20:05:10.000Z","date":"2022-07-11","kind":"purchase","acquired":true,"shares":500,"price":0.495,"value":247.5,"ownership":{"direct":true},"balance_after":625049,"source":{"system":"sec-edgar","filing":"0001493152-22-019076","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222019076/ownership.xml","form_type":"4"}},{"id":2208463,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-07-12T20:05:10.000Z","date":"2022-07-11","kind":"purchase","acquired":true,"shares":1000,"price":0.3939,"value":393.9,"ownership":{"direct":true},"balance_after":624549,"source":{"system":"sec-edgar","filing":"0001493152-22-019076","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222019076/ownership.xml","form_type":"4"}},{"id":2208462,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-07-12T20:05:10.000Z","date":"2022-07-08","kind":"purchase","acquired":true,"shares":2500,"price":0.155,"value":387.5,"ownership":{"direct":true},"balance_after":623549,"source":{"system":"sec-edgar","filing":"0001493152-22-019076","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222019076/ownership.xml","form_type":"4"}},{"id":2208461,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-07-12T20:05:10.000Z","date":"2022-07-08","kind":"purchase","acquired":true,"shares":1600,"price":0.2,"value":320.0,"ownership":{"direct":true},"balance_after":621049,"source":{"system":"sec-edgar","filing":"0001493152-22-019076","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222019076/ownership.xml","form_type":"4"}},{"id":2302231,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-04-06T20:08:08.000Z","date":"2022-04-05","kind":"purchase","acquired":true,"shares":1050,"price":0.4829,"value":507.045,"ownership":{"direct":true},"balance_after":619449,"source":{"system":"sec-edgar","filing":"0001493152-22-009276","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222009276/ownership.xml","form_type":"4"}},{"id":2302230,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-04-06T20:08:08.000Z","date":"2022-04-04","kind":"purchase","acquired":true,"shares":1404,"price":0.6,"value":842.4,"ownership":{"direct":true},"balance_after":618399,"source":{"system":"sec-edgar","filing":"0001493152-22-009276","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222009276/ownership.xml","form_type":"4"}},{"id":2302229,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-04-06T20:08:08.000Z","date":"2022-04-04","kind":"purchase","acquired":true,"shares":4096,"price":0.45,"value":1843.2,"ownership":{"direct":true},"balance_after":616995,"source":{"system":"sec-edgar","filing":"0001493152-22-009276","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222009276/ownership.xml","form_type":"4"}},{"id":2302228,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-04-06T20:08:08.000Z","date":"2022-04-04","kind":"purchase","acquired":true,"shares":500,"price":0.59,"value":295.0,"ownership":{"direct":true},"balance_after":612899,"source":{"system":"sec-edgar","filing":"0001493152-22-009276","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222009276/ownership.xml","form_type":"4"}},{"id":2302227,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-04-06T20:08:08.000Z","date":"2022-04-04","kind":"purchase","acquired":true,"shares":11000,"price":0.5,"value":5500.0,"ownership":{"direct":true},"balance_after":612399,"source":{"system":"sec-edgar","filing":"0001493152-22-009276","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222009276/ownership.xml","form_type":"4"}},{"id":2397190,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series C-2 Preferred Stock","published_at":"2022-02-14T23:36:36.000Z","date":"2021-10-25","kind":"grant","acquired":true,"shares":100,"ownership":{"direct":false,"nature":"Held by Quintel-MC, Incorporated"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The Series C-2 designates 100 shares for issuance, par value $0.0001 per share. Each share of Series C-2 is convertible into 73,215 shares of the Company's common stock and is entitled to vote on all matters submitted to the Company's stockholders on an as-converted basis. Other than the conversion and voting rights, there are no other preferences."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares of preferred stock were acquired in connection with the cancellation of 7,321,429 shares of the Company's common stock that were held by Quintel-MC, Incorporated."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001493152-22-004599","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222004599/ownership.xml","form_type":"5"}},{"id":2397189,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-14T23:36:36.000Z","date":"2021-10-25","kind":"disposition_to_issuer","acquired":false,"shares":7321429,"ownership":{"direct":false,"nature":"Held by Quintel-MC, Incorporated"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were cancelled in connection with the designation of 100 shares of Series C-2 Convertible Preferred Stock to Quintel-MC, Incorporated."}],"balance_after":4047054,"source":{"system":"sec-edgar","filing":"0001493152-22-004599","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222004599/ownership.xml","form_type":"5"}},{"id":2397188,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-14T23:36:36.000Z","date":"2021-12-21","kind":"purchase","acquired":true,"shares":1000,"price":0.9024,"value":902.4,"ownership":{"direct":true},"balance_after":601399,"source":{"system":"sec-edgar","filing":"0001493152-22-004599","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222004599/ownership.xml","form_type":"5"}},{"id":2397187,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-14T23:36:36.000Z","date":"2021-12-21","kind":"purchase","acquired":true,"shares":500,"price":0.9998,"value":499.9,"ownership":{"direct":true},"balance_after":600399,"source":{"system":"sec-edgar","filing":"0001493152-22-004599","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000149315222004599/ownership.xml","form_type":"5"}},{"id":2640522,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":124575,"kind":"person","name":"Wert Lawrence","position":1,"cik":"0001626623","reported_name":"Wert Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2021-07-07T01:56:21.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":28000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares issued upon exchange of non-qualified incentive options for an equivalent number of shares of common stock."}],"balance_after":28000000,"derivative":{"exercise_price":0.1,"expiration_date":"2026-06-30","underlying":"Common Stock","underlying_shares":28000000},"source":{"system":"sec-edgar","filing":"0001415889-21-003532","document":"form4a-07062021_060702.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000141588921003532/form4a-07062021_060702.xml","form_type":"4/A","original_submission_date":"2021-07-02"}},{"id":2640521,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":124575,"kind":"person","name":"Wert Lawrence","position":1,"cik":"0001626623","reported_name":"Wert Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2021-07-07T01:56:21.000Z","date":"2021-03-31","kind":"disposition_to_issuer","acquired":false,"shares":3500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares issued as director compensation."}],"balance_after":0,"derivative":{"exercise_price":0.025,"exercise_date":"2021-01-22","expiration_date":"2023-01-22","underlying":"Common Stock","underlying_shares":3500000},"source":{"system":"sec-edgar","filing":"0001415889-21-003532","document":"form4a-07062021_060702.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000141588921003532/form4a-07062021_060702.xml","form_type":"4/A","original_submission_date":"2021-07-02"}},{"id":2640520,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":124575,"kind":"person","name":"Wert Lawrence","position":1,"cik":"0001626623","reported_name":"Wert Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-07T01:56:21.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":28000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of options to purchase common stock at a price of $0.10 per share. One-half of the stock options vest upon the effective date of a 1:28 reverse stock split of the Issuer's common stock, and the remainder vest on June 30, 2022, subject to continued service as a director of the Issuer."}],"balance_after":36620297,"source":{"system":"sec-edgar","filing":"0001415889-21-003532","document":"form4a-07062021_060702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000141588921003532/form4a-07062021_060702.xml","form_type":"4/A","original_submission_date":"2021-07-02"}},{"id":2640519,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":124575,"kind":"person","name":"Wert Lawrence","position":1,"cik":"0001626623","reported_name":"Wert Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-07T01:56:21.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":3500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares issued upon exchange of non-qualified incentive options for an equivalent number of shares of common stock."}],"balance_after":8620297,"source":{"system":"sec-edgar","filing":"0001415889-21-003532","document":"form4a-07062021_060702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000141588921003532/form4a-07062021_060702.xml","form_type":"4/A","original_submission_date":"2021-07-02"}},{"id":2640518,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":124575,"kind":"person","name":"Wert Lawrence","position":1,"cik":"0001626623","reported_name":"Wert Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-07T01:56:21.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":65789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares issued as director compensation."}],"balance_after":8620297,"source":{"system":"sec-edgar","filing":"0001415889-21-003532","document":"form4a-07062021_060702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000141588921003532/form4a-07062021_060702.xml","form_type":"4/A","original_submission_date":"2021-07-02"}},{"id":2640524,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":137402,"kind":"person","name":"Berman Nathan Joel","position":1,"cik":"0001871296","reported_name":"Berman Nathan Joel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CONTROLLER & PRIN ACTNG OFCR"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-07-06T21:28:38.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":496957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-half of the stock options vest upon the effective date of a 1:28 reverse stock split of the Issuer's common stock, and the remainder vest on June 30, 2022, subject to continued employment with the Issuer."}],"balance_after":496957,"derivative":{"exercise_price":0.1,"expiration_date":"2026-06-30","underlying":"Common Stock","underlying_shares":496957},"source":{"system":"sec-edgar","filing":"0001415889-21-003515","document":"form4-07062021_020722.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000141588921003515/form4-07062021_020722.xml","form_type":"4"}},{"id":2640523,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":137402,"kind":"person","name":"Berman Nathan Joel","position":1,"cik":"0001871296","reported_name":"Berman Nathan Joel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CONTROLLER & PRIN ACTNG OFCR"}}],"security":"Common Stock","published_at":"2021-07-06T21:28:38.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":496957,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock of the Issuer were acquired in exchange for shares of common stock of Panacea Life Sciences, Inc. (\"Panacea\"), in connection with the Securities Exchange Agreement dated June 30, 2021 by and among the Issuer, Panacea and the shareholders of Panacea."}],"balance_after":496957,"source":{"system":"sec-edgar","filing":"0001415889-21-003515","document":"form4-07062021_020722.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000141588921003515/form4-07062021_020722.xml","form_type":"4"}},{"id":2643690,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":124575,"kind":"person","name":"Wert Lawrence","position":1,"cik":"0001626623","reported_name":"Wert Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2021-07-02T20:16:39.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":28000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-half of the stock options vest upon the effective date of a 1:28 reverse stock split of the Issuer's common stock, and the remainder vest on June 30, 2022, subject to continued service as a director of the Issuer."}],"balance_after":28000000,"derivative":{"exercise_price":0.1,"expiration_date":"2026-06-30","underlying":"Common Stock","underlying_shares":28000000},"source":{"system":"sec-edgar","filing":"0001415889-21-003399","document":"form4-07022021_010704.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000141588921003399/form4-07022021_010704.xml","form_type":"4"}},{"id":2643688,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Series D Preferred Stock","published_at":"2021-07-02T20:05:21.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":10000,"ownership":{"direct":false,"nature":"Held by J&N Real Estate Company LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of preferred stock were acquired in exchange for shares of preferred stock of Panacea, in connection with the Exchange Agreement."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001415889-21-003386","document":"form4-07022021_040701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000141588921003386/form4-07022021_040701.xml","form_type":"4"}},{"id":2643687,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Series C-1 Preferred Stock","published_at":"2021-07-02T20:05:21.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":10000,"ownership":{"direct":false,"nature":"Held by Quintel-MC, Incorporated"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of preferred stock were acquired in exchange for shares of preferred stock of Panacea, in connection with the Exchange Agreement."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001415889-21-003386","document":"form4-07022021_040701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000141588921003386/form4-07022021_040701.xml","form_type":"4"}},{"id":2643686,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Series C Preferred Stock","published_at":"2021-07-02T20:05:21.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":1000000,"ownership":{"direct":false,"nature":"Held by Quintel-MC, Incorporated"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of preferred stock were acquired in exchange for shares of preferred stock of Panacea, in connection with the Exchange Agreement."}],"balance_after":1000000,"source":{"system":"sec-edgar","filing":"0001415889-21-003386","document":"form4-07022021_040701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000141588921003386/form4-07022021_040701.xml","form_type":"4"}},{"id":2643685,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2021-07-02T20:05:21.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":318317499,"ownership":{"direct":false,"nature":"Held by Quintel-MC, Incorporated"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were acquired in exchange for shares of common stock of Panacea Life Sciences, Inc. (\"Panacea\"), in connection with the Securities Exchange Agreement dated June 30, 2021 between the Issuer, Panacea and the shareholders of Panacea (the \"Exchange Agreement\")."}],"balance_after":318317499,"source":{"system":"sec-edgar","filing":"0001415889-21-003386","document":"form4-07022021_040701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000141588921003386/form4-07022021_040701.xml","form_type":"4"}},{"id":2643684,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":109558,"kind":"person","name":"Buttorff Leslie","position":1,"cik":"0001866792","reported_name":"Buttorff Leslie","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2021-07-02T20:05:21.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":16797145,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were acquired in exchange for shares of common stock of Panacea Life Sciences, Inc. (\"Panacea\"), in connection with the Securities Exchange Agreement dated June 30, 2021 between the Issuer, Panacea and the shareholders of Panacea (the \"Exchange Agreement\")."}],"balance_after":16797145,"source":{"system":"sec-edgar","filing":"0001415889-21-003386","document":"form4-07022021_040701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000141588921003386/form4-07022021_040701.xml","form_type":"4"}},{"id":2884721,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":143186,"kind":"person","name":"Alberttis Alvaro Daniel","position":1,"cik":"0001801089","reported_name":"Alberttis Alvaro Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Options to purchase common stock","published_at":"2021-02-02T18:57:33.000Z","date":"2021-01-22","kind":"grant","acquired":true,"shares":2500000,"price":0.025,"value":62500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"(1)\tThe reporting person was granted two year options to purchase 2,500,000 shares of Common Stock at an exercise price of $0.025 per share. Provided Mr. Alberttis has not resigned or been removed prior to vesting, fifty (50%) percent of such amount shall vest upon his execution of the Corporation's Annual Report on Form 10-K for filing with the SEC for the Corporation's fiscal year ended December 31, 2020 on or prior to the due date thereof, including any and all Certifications thereto required to be executed by Mr. Alberttis under the Sarbanes-Oxley Act of 2002 (as well as any amendments and any other SEC filings or reports as requested) and fifty (50%) percent upon the closing of any acquisition with a combined value (target and the Corporation) in excess of five million ($5,000,000) dollars (the \"Acquisition\"). (continued, see Footnote 4)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(cont'd) Upon closing of an Acquisition, all options shall immediately vest if, and only if, a new chief financial and chief executive officer is appointed who will be responsible for filing and certifying the Form 10-K, provided Mr. Alberttis shall also be required to render reasonable assistance in connection therewith upon request."}],"balance_after":2500000,"derivative":{"exercise_price":0.025,"exercise_date":"2012-01-22","expiration_date":"2023-01-22","underlying":"Common stock","underlying_shares":2500000},"source":{"system":"sec-edgar","filing":"0001415889-21-000480","document":"form4-02022021_100218.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000141588921000480/form4-02022021_100218.xml","form_type":"4"}},{"id":2884720,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":143186,"kind":"person","name":"Alberttis Alvaro Daniel","position":1,"cik":"0001801089","reported_name":"Alberttis Alvaro Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common stock","published_at":"2021-02-02T18:57:33.000Z","date":"2021-01-22","kind":"grant","acquired":true,"shares":2039241,"price":0.025,"value":50981.025,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person was issued a total of 2,039,241 shares of common stock in payment of accrued compensation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 2,277,337 shares of common stock, together with options to purchase 2,500,00 shares of common stock at a price of $0.025 per share, exercisable until 1/22/23."}],"balance_after":4777337,"source":{"system":"sec-edgar","filing":"0001415889-21-000480","document":"form4-02022021_100218.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000141588921000480/form4-02022021_100218.xml","form_type":"4"}},{"id":2884723,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":143187,"kind":"person","name":"Johnson Andrew L.","position":1,"cik":"0001773143","reported_name":"Johnson Andrew L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF GROWTH OFFICER"}}],"security":"Options to purchase common stock","published_at":"2021-02-02T18:56:15.000Z","date":"2021-01-22","kind":"grant","acquired":true,"shares":3500000,"price":0.025,"value":87500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted two year options to purchase 3,500,000 shares of Common Stock at an exercise price of $0.025 per share. Provided Mr. Johnson has not resigned or been removed prior to vesting, fifty (50%) percent of such amount shall vest upon issuance and fifty (50%) percent upon the closing of any acquisition with a combined value (target and the Corporation) in excess of five million ($5,000,000) dollars."}],"balance_after":3500000,"derivative":{"exercise_price":0.025,"exercise_date":"2021-01-22","expiration_date":"2023-01-22","underlying":"Common stock","underlying_shares":3500000},"source":{"system":"sec-edgar","filing":"0001415889-21-000478","document":"form4-02022021_100200.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000141588921000478/form4-02022021_100200.xml","form_type":"4"}},{"id":2884722,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":143187,"kind":"person","name":"Johnson Andrew L.","position":1,"cik":"0001773143","reported_name":"Johnson Andrew L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF GROWTH OFFICER"}}],"security":"Common Stock","published_at":"2021-02-02T18:56:15.000Z","date":"2021-01-22","kind":"grant","acquired":true,"shares":8186240,"price":0.025,"value":204656.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person was issued a total of 8,186,240 shares of common stock in payment of accrued compensation, reimbursable expenses, and loans advanced to the company."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 8,498,740 shares of common stock, together with: (i) options to purchase 31,250 shares of common stock at a price of $0.96 per share, exercisable until 1/15/29; (ii) options to purchase 12,500 shares of common stock at a price of $0.32 per share, exercisable until 1/15/29; (iii) options to purchase 750,000 shares of common stock at a price of $0.32 per share, exercisable until 3/12/29; and (iv) options to purchase 3,500,00 shares of common stock at a price of $0.025 per share, exercisable until 1/22/23."}],"balance_after":12792490,"source":{"system":"sec-edgar","filing":"0001415889-21-000478","document":"form4-02022021_100200.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000141588921000478/form4-02022021_100200.xml","form_type":"4"}},{"id":3286236,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":143187,"kind":"person","name":"Johnson Andrew L.","position":1,"cik":"0001773143","reported_name":"Johnson Andrew L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Common Stock","published_at":"2020-02-06T20:08:13.000Z","date":"2020-02-01","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Consists of 312,500 shares of common stock, together with: (i) options to purchase 31,250 shares of common stock at a price of $0.96 per share, exercisable until 1/15/29; (ii) options to purchase 12,500 shares of common stock at a price of $0.32 per share, exercisable until 1/15/29; and (iii) options to purchase 750,000 shares of common stock at a price of $0.32 per share, exercisable until 3/12/29"}],"balance_after":1106250,"source":{"system":"sec-edgar","filing":"0001415889-20-000288","document":"form4-02062020_120200.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000141588920000288/form4-02062020_120200.xml","form_type":"4"}},{"id":3286235,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":151883,"kind":"person","name":"Puzder Ken","position":1,"cik":"0001764453","reported_name":"Puzder Ken","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2020-02-06T20:07:21.000Z","date":"2020-02-01","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Consists of 250,000 shares of common stock as reported herein, together with options to purchase 250,000 shares of common stock at a price of $0.20 per share, exercisable until 1/11/29"}],"balance_after":500000,"source":{"system":"sec-edgar","filing":"0001415889-20-000287","document":"form4-02062020_120208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000141588920000287/form4-02062020_120208.xml","form_type":"4"}},{"id":3334970,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":143187,"kind":"person","name":"Johnson Andrew L.","position":1,"cik":"0001773143","reported_name":"Johnson Andrew L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Common Stock","published_at":"2019-12-19T21:37:21.000Z","date":"2019-12-18","kind":"purchase","acquired":true,"shares":62500,"price":0.4,"value":25000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Consists of 62,500 shares of common stock as reported herein, together with: (i) options to purchase 31,250 shares shares of common stock at a price of $0.96 per share, exercisable until 1/15/29; (ii) options to purchase 12,500 shares of common stock at a price of $0.32 per share, exercisable until 1/15/29; and (iii) options to purchase 750,000 shares of common stock at a price of $0.32 per share, exercisable until 3/12/29"}],"balance_after":856250,"source":{"system":"sec-edgar","filing":"0001415889-19-001542","document":"form4-12192019_011208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000141588919001542/form4-12192019_011208.xml","form_type":"4"}},{"id":3342108,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":153134,"kind":"person","name":"Ceed2Med LLC","position":1,"cik":"0001764452","reported_name":"Ceed2Med LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153135,"kind":"person","name":"Yampolsky Vladislav","position":2,"cik":"0001782054","reported_name":"Yampolsky Vladislav","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, Par Value $0.0001 per Share","published_at":"2019-12-13T22:39:04.000Z","date":"2019-12-11","kind":"other","acquired":false,"shares":1200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Exactus, Inc. (the \"Issuer\"), par value $0.0001 per share (\"Shares\"), that were distributed by Ceed2Med, LLC (\"C2M\") to one of its non-managing members in connection with its internal operational purposes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This statement is jointly filed by and on behalf of each of C2M and Mr. Vladislav Yampolsky (the \"Reporting Persons\").  Mr. Yampolsky is the Managing Member of C2M.  As such, Mr. Yampolsky may be deemed to beneficially own securities owned by C2M."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The Reporting Persons state that neither the filing of this statement nor anything herein shall be deemed an admission that such persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\") or otherwise, the beneficial owners of any securities covered by this statement. The reporting persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such persons in such securities."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Represents Shares directly beneficially owned by C2M."}],"balance_after":6435691,"source":{"system":"sec-edgar","filing":"0001415889-19-001504","document":"form4-12132019_021251.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000141588919001504/form4-12132019_021251.xml","form_type":"4"}},{"id":3360805,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":107891,"kind":"person","name":"Price John C","position":1,"cik":"0001636242","reported_name":"Price John C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-22T23:04:40.000Z","date":"2019-11-20","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of restricted common stock that vests equally over 24 months commencing the date of grant, subject to the reporting person's continued service as director."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001415889-19-001390","document":"form4-11222019_031127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000141588919001390/form4-11222019_031127.xml","form_type":"4"}},{"id":3360850,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":21929,"kind":"person","name":"Thompson Jeffrey M","position":1,"cik":"0001397565","reported_name":"Thompson Jeffrey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-22T23:03:32.000Z","date":"2019-11-20","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of restricted common stock that vests equally over 24 months commencing the date of grant, subject to the reporting person's continued service as director."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001415889-19-001389","document":"form4-11222019_031118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1397565/000141588919001389/form4-11222019_031118.xml","form_type":"4"}},{"id":3361088,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":153604,"kind":"person","name":"ESVAL KEVIN JAMES","position":1,"cik":"0001438014","reported_name":"ESVAL KEVIN JAMES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-22T18:00:50.000Z","date":"2019-11-20","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of restricted common stock that vests equally over 24 months commencing the date of grant, subject to the reporting person's continued service as director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects adjustment for the 1:8 reverse split of common stock, effective February 25, 2019."}],"balance_after":100250,"source":{"system":"sec-edgar","filing":"0001415889-19-001388","document":"form4-11222019_031136.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438014/000141588919001388/form4-11222019_031136.xml","form_type":"4"}},{"id":3374092,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":153867,"kind":"person","name":"Schwartz Steven A","position":1,"cik":"0001782553","reported_name":"Schwartz Steven A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-12T17:47:53.000Z","date":"2019-06-24","kind":"grant","acquired":true,"shares":98040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted common stock vest in accordance with the following schedule: 4,085 vested upon the date of grant and the remainder shall vest equally on the first calendar date of each month thereafter until fully vested."}],"balance_after":223040,"source":{"system":"sec-edgar","filing":"0001415889-19-001280","document":"form4-11122019_091140.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000141588919001280/form4-11122019_091140.xml","form_type":"4"}},{"id":3396468,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":154538,"kind":"person","name":"Aloi Emiliano Angel","position":1,"cik":"0001774524","reported_name":"Aloi Emiliano Angel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND INTERIM CEO"}}],"security":"Common Stock","published_at":"2019-10-07T16:47:17.000Z","date":"2019-09-13","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of shares of restricted common stock that commence vesting upon the satisfaction of certain performance conditions, after which the shares shall vest equally over 48 months."}],"balance_after":1000000,"source":{"system":"sec-edgar","filing":"0001415889-19-001156","document":"form4-10072019_091000.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000141588919001156/form4-10072019_091000.xml","form_type":"4"}}],"next_cursor":"2019-10-07T16:47:17.000000Z,3396468"}